中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
1期
46-47
,共2页
李明生%卢明友%魏厚华%李济福%任琳%史大环
李明生%盧明友%魏厚華%李濟福%任琳%史大環
리명생%로명우%위후화%리제복%임림%사대배
肺纤维化%阿魏酸钠
肺纖維化%阿魏痠鈉
폐섬유화%아위산납
Pulmonary fibrosis%Sodium ferulate injection
目的 探讨阿魏酸钠对特发性肺纤维化患者血清结缔组织生长因子(CTGF)、基质金属蛋白酶-9(MMP-9)、组织抑制物-1(TIMP-1)的影响.方法 46例特发性肺纤维化患者随机分为对照组20例给予常规治疗;治疗组26例在常规治疗基础上加用阿魏酸钠.治疗前后检测血清CTGF、MMP-9、TIMP-1.结果 治疗组治疗后CTGF、MMP-9、TIMP-1均有明显改善,与对照组比较差异有统计学意义(P<0.05).结论 阿魏酸钠可能通过改善血清CTGF、MMP-9、TIMP-1水平而改善特发性肺纤维化患者的病情.
目的 探討阿魏痠鈉對特髮性肺纖維化患者血清結締組織生長因子(CTGF)、基質金屬蛋白酶-9(MMP-9)、組織抑製物-1(TIMP-1)的影響.方法 46例特髮性肺纖維化患者隨機分為對照組20例給予常規治療;治療組26例在常規治療基礎上加用阿魏痠鈉.治療前後檢測血清CTGF、MMP-9、TIMP-1.結果 治療組治療後CTGF、MMP-9、TIMP-1均有明顯改善,與對照組比較差異有統計學意義(P<0.05).結論 阿魏痠鈉可能通過改善血清CTGF、MMP-9、TIMP-1水平而改善特髮性肺纖維化患者的病情.
목적 탐토아위산납대특발성폐섬유화환자혈청결체조직생장인자(CTGF)、기질금속단백매-9(MMP-9)、조직억제물-1(TIMP-1)적영향.방법 46례특발성폐섬유화환자수궤분위대조조20례급여상규치료;치료조26례재상규치료기출상가용아위산납.치료전후검측혈청CTGF、MMP-9、TIMP-1.결과 치료조치료후CTGF、MMP-9、TIMP-1균유명현개선,여대조조비교차이유통계학의의(P<0.05).결론 아위산납가능통과개선혈청CTGF、MMP-9、TIMP-1수평이개선특발성폐섬유화환자적병정.
Objective To explore the effects of sodium ferulate injection on CTGF, MMP-9 and TIMP-I in the serum of the patients with idiopathic pulmonary fibrosis(IPF). Methods 46 cases with IPF were randomly divid-ed into control group of 20 eases and treatment group of 26 cases. Control group was given the usual treatment and the treatment group was given the usual treatment and sodium ferulate injection. The levels of CTGF, MMP-9 and TIMP-1 in the serum were measured before and after treatment. Results After treatment,the concentration of CTGF,MMP-9 and TIMP-1 in patients in the treatment group was significantly improved than that in the control group(P < 0.05). Conclusion The treatment with sodium ferulate injection could improve the IPF through improving the production of CTGF,MMP-9 and TIMP-1.